Hermetica Superfood Encyclopedia
The Short Answer
Two-row barley delivers a spectrum of bioactives — including β-glucans, ferulic acid (bound fraction 104–365 μg/g), proanthocyanidins (15.8–131.8 μg/g), and α-tocotrienol-dominant tocols (70.6–76.8% of total tocols, 19.2–54.6 μg/g DW) — that collectively exert antioxidant, cholesterol-lowering, and glycemic-modulating effects through radical scavenging, gut viscosity, and enzyme inhibition pathways. Whole-grain two-row barley provides approximately 6 g dietary fiber per 100 g along with meaningful quantities of niacin, vitamin B6, iron, zinc, selenium, and manganese, supporting cardiovascular and metabolic health, though robust human clinical trial data with quantified effect sizes remain limited.
CategoryOther
GroupAncient Grains
Evidence LevelPreliminary
Primary Keywordtwo-row barley benefits
Two-row Barley — botanical close-up
Health Benefits
**Cardiovascular Protection**
β-Glucan fiber and phenolic acids, including ferulic acid and p-coumaric acid (15–374 μg/g), lower LDL cholesterol by increasing viscosity in the gut, reducing bile acid reabsorption, and suppressing hepatic cholesterol synthesis, supporting heart health.
**Antioxidant Defense**: Total phenolic content ranging from 3
21–9.73 mg GAE/g DW and ABTS radical scavenging values up to 9 mM TE/g confer broad-spectrum antioxidant activity, protecting cellular membranes and DNA from oxidative damage mediated by reactive oxygen species.
**Glycemic Regulation**
β-Glucans and phenolics slow carbohydrate digestion by increasing intestinal chyme viscosity and inhibiting α-amylase and α-glucosidase enzymes, thereby blunting postprandial glucose and insulin excursions and improving insulin sensitivity.
**Anti-inflammatory and Antiproliferative Effects**
Proanthocyanidins (dominated by prodelphinidin B3 at 90–197 μg/g) and tocotrienols reduce lipid peroxidation, suppress pro-inflammatory cytokine signaling, and inhibit cancer cell proliferation in preclinical models.
**Hormonal and Antioxidant Support via Lignans**
The lignan 7-hydroxymatairesinol, present at approximately 541 μg/100 g, undergoes enteroligation conversion to enterolactone, supporting estrogen receptor modulation and antioxidant defense in hormone-sensitive tissues.
**Micronutrient Repletion**
Two-row barley supplies iron, zinc, selenium, manganese, niacin, and vitamin B6 per 100 g serving, supporting enzymatic cofactor roles in energy metabolism, immune function, thyroid health, and neurotransmitter synthesis.
**Vitamin E (Tocotrienol) Activity**
α-Tocotrienol constitutes approximately 47.7% of total tocols (19.2–54.6 μg/g DW), and tocotrienols as a class demonstrate superior membrane mobility and neuroprotective antioxidant potency compared to tocopherols, potentially reducing oxidative neuroinflammation.
Origin & History
Natural habitat
Two-row barley (Hordeum vulgare var. distichon) originated in the Fertile Crescent of the Near East, with cultivation dating back over 10,000 years, making it one of the earliest domesticated cereal crops. It thrives in temperate climates across Europe, North America, and parts of Asia, preferring well-drained loamy soils with moderate rainfall and cool growing seasons. Two-row varieties, which bear grain on only two of six possible rows along the spike, are prized in malting and brewing industries for their higher starch content and lower protein compared to six-row varieties, and are widely cultivated in regions such as the United Kingdom, Germany, Scandinavia, and the Northern United States.
“Barley holds the distinction of being among the world's first cultivated cereals, with archaeological evidence from the Fertile Crescent dating cultivation to approximately 8000 BCE, and two-row forms are considered among the earliest domesticated variants selected for their large, uniform kernels. In ancient Egypt and Mesopotamia, barley was a foundational dietary staple and currency crop, used to make flatbreads, porridges, and the earliest recorded fermented beverages; the Sumerian hymn to Ninkasi (~1800 BCE) describes barley-based beer production in detail. Greco-Roman physicians including Hippocrates and Dioscorides documented barley water (ptisane) as a therapeutic preparation for fever, gastrointestinal complaints, and convalescence, establishing one of the earliest recorded uses of a grain as a medicinal food. In medieval European monastic traditions, barley remained central to both nutritional sustenance and ale production, and its cultivation spread globally during colonial expansion, embedding it deeply in the agricultural and culinary heritage of Europe, the Middle East, South Asia, and East Africa.”Traditional Medicine
Scientific Research
The evidence base for two-row barley's bioactive effects currently rests predominantly on in vitro antioxidant assays, phytochemical characterization studies, and preclinical models rather than registered human clinical trials with quantified effect sizes. Compositional studies across Pakistani, European, and North American cultivars have reproducibly quantified phenolic acid profiles, tocol distribution, proanthocyanidin concentrations, and ABTS/DPPH radical scavenging values, providing a mechanistically coherent but clinically unvalidated foundation. General barley β-glucan research (not variety-specific to two-row) has informed the European Food Safety Authority (EFSA) and FDA qualified health claims for LDL cholesterol reduction at ≥3 g/day intake, lending indirect supporting evidence for the cardiovascular benefits of two-row barley consumption. Authors of the most recent phytochemical surveys explicitly call for future human bioavailability and intervention trials, indicating that the scientific community considers the clinical translation of these in vitro findings to be an open and prioritized research question.
Preparation & Dosage
Traditional preparation
**Whole Grain (Cooked Pearled or Hulled Barley)**
50–100 g dry weight per serving (approximately 1/4–1/2 cup), providing ~6 g fiber/100 g; recommended as a dietary staple rather than a supplement
**Barley Flour**
Incorporated into baked goods at 20–50% flour substitution to increase β-glucan and phenolic content; no standardized therapeutic dose established.
**Malted Barley / Wort**
Traditional and modern brewing preparation concentrates polyphenols (15.68–20.20 μg/g in wort); not recommended as a medicinal delivery format due to fermentation-related compound transformation and alcohol content.
**Barley Grass Powder**
3–5 g/day used in functional food contexts for chlorophyll and antioxidant content, though phytochemical profiles differ substantially from mature grain
Young leaf powder at .
**β-Glucan Extract**
3 g β-glucan/day is supported by EFSA and FDA for LDL cholesterol claims; two-row specific extraction products are not yet commercially standardized
Based on broader barley β-glucan evidence, a minimum of .
**Timing**
Whole grain barley consumed with main meals to maximize the glycemic-blunting viscosity effect of β-glucans on co-ingested carbohydrates.
**Standardization Note**
No commercial two-row barley extract is currently standardized to a specific percentage of ferulic acid, proanthocyanidins, or tocols; phytochemical content varies considerably by cultivar and processing method.
Nutritional Profile
Two-row barley (whole grain, cooked) provides approximately 123 kcal, 28 g carbohydrates, 3.6 g protein, 0.4 g total fat (with linoleic acid and palmitic acid at 11.8–12.7% of fatty acids), and 6 g dietary fiber per 100 g. Micronutrients include niacin (B3), vitamin B6, folate (supported by identified folate bioactives), iron, zinc, selenium, and manganese, all contributing to enzymatic, hematopoietic, and neurological functions. Key phytochemicals include ferulic acid (bound: 104–365 μg/g), p-coumaric acid (15–374 μg/g), proanthocyanidins (15.8–131.8 μg/g; prodelphinidin B3 dominant), α-tocotrienol (~47.7% of total tocols; total tocols 19.2–54.6 μg/g DW), γ-sitosterol, 7-hydroxymatairesinol (~541 μg/100 g), β-glucan, abscisic acid (7.37–235.46 ng/g), and chlorogenic acids. Bioavailability of phenolic acids is influenced substantially by food matrix: bound ferulic acid requires enzymatic or fermentative release in the colon, limiting proximal absorption but enabling prebiotic and microbiome-mediated metabolic activity; processing methods such as pearling, malting, and fermentation significantly alter phytochemical concentrations and bioaccessibility.
How It Works
Mechanism of Action
β-Glucans form a viscous gel matrix in the small intestine that slows nutrient absorption, reduces bile acid reabsorption, and signals hepatic LDL receptor upregulation, collectively lowering circulating LDL cholesterol; simultaneously, β-glucans interact with Dectin-1 and Toll-like receptor pathways to modulate innate immune responses. Ferulic acid and other hydroxycinnamic acids donate hydrogen atoms to neutralize free radicals (ABTS scavenging up to 9 mM TE/g), inhibit cyclooxygenase and lipoxygenase enzymes to reduce eicosanoid-driven inflammation, and upregulate Nrf2-mediated antioxidant response element (ARE) gene expression including heme oxygenase-1 and glutathione S-transferase. Proanthocyanidins, particularly prodelphinidin B3, induce apoptosis in proliferating cancer cell lines through caspase activation and downregulation of Bcl-2 anti-apoptotic proteins, while also inhibiting NF-κB translocation to suppress inflammatory cytokine transcription. Abscisic acid (ABA, 7.37–235.46 ng/g) activates the LANCL2 receptor pathway and stimulates AMPK phosphorylation, enhancing glucose uptake in immune and metabolic cells and contributing to insulin-independent glycemic regulation.
Clinical Evidence
No randomized controlled trials (RCTs) or cohort studies have been identified that specifically examine two-row barley (Hordeum vulgare var. distichon) as an isolated intervention with human participants and reported quantitative effect sizes. The available human-relevant evidence is extrapolated from the broader barley literature, where β-glucan supplementation (≥3 g/day from mixed barley sources) has demonstrated LDL cholesterol reductions of approximately 0.2–0.3 mmol/L in meta-analyses, though these findings are not disaggregated by barley subspecies or row-type. In vitro and compositional research on two-row barley cultivars from Pakistan demonstrated TPC values of 37.5–43.8 mg GAE/100g and ABTS scavenging up to 12.6 mM TE/g, identifying considerable antioxidant potential, but direct translation to clinical outcomes has not been tested. Confidence in variety-specific clinical benefits of two-row barley therefore remains low, and consumption as a whole grain within a balanced diet is the best-supported practical recommendation pending dedicated human trials.
Safety & Interactions
Two-row barley consumed as a whole grain is considered safe for the general adult population and is classified as a conventional food ingredient with no established upper tolerable intake level; no serious adverse events have been reported in the phytochemical literature surveyed. Individuals with celiac disease or confirmed wheat-barley-rye gluten sensitivity must avoid all barley products, as Hordeum vulgare contains hordein, a prolamin protein that triggers immune-mediated intestinal damage in these populations. Persons with diagnosed gluten sensitivity should note that barley β-glucan supplements may be contraindicated even when labeled gluten-free, unless certified through rigorous third-party testing. No specific drug interactions have been documented for two-row barley phytochemicals in human pharmacokinetic studies; however, the fiber content and potential enzyme-inhibitory activity of β-glucans and phenolics theoretically could modestly delay oral drug absorption if consumed concurrently, and individuals on hypoglycemic medications should monitor blood glucose when substantially increasing barley intake. Safety data during pregnancy and lactation are not specifically reported for two-row barley beyond its status as a traditional food; whole grain consumption at typical dietary amounts is generally considered safe, but concentrated extracts or supplements lack safety evaluation in these populations.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Hordeum vulgare var. distichonTwo-rowed barleyMalting barleyDistichon barleyTwo-row malt barley
Frequently Asked Questions
What makes two-row barley different from six-row barley nutritionally?
Two-row barley (Hordeum vulgare var. distichon) produces grain on only two of six spike rows, yielding larger, more uniform kernels with higher starch content and lower protein compared to six-row varieties, making it preferred for malting. Phytochemically, two-row varieties contain comparable β-glucan, ferulic acid (bound: 104–365 μg/g), and tocotrienol profiles to other barley types, though proanthocyanidin content varies by hull color and cultivar (15.8–131.8 μg/g), and specific compositional differences versus six-row barley are not fully characterized in head-to-head studies.
Does eating barley actually lower cholesterol?
Yes, based on consistent evidence from the broader barley literature: the FDA and EFSA both recognize a qualified health claim that consuming at least 3 g of barley β-glucan per day can reduce LDL cholesterol by approximately 0.2–0.3 mmol/L, sufficient to be physiologically meaningful. This effect is driven by β-glucan forming a viscous gel in the intestine that reduces bile acid reabsorption and upregulates hepatic LDL receptors; however, these findings are from general barley studies and have not been replicated in trials isolating two-row barley specifically.
Is two-row barley safe for people with gluten intolerance?
No — two-row barley contains hordein, a prolamin-class gluten protein that is immunologically reactive in individuals with celiac disease and non-celiac gluten sensitivity, triggering intestinal inflammation and villous atrophy in susceptible persons. Anyone diagnosed with celiac disease must strictly avoid all barley products, including barley flour, malt, barley grass, and β-glucan supplements derived from barley, regardless of processing method, as hordein cannot be removed without specialized enzymatic treatment.
What are the main antioxidants in two-row barley and how potent are they?
Two-row barley's primary antioxidants include ferulic acid (the most abundant phenolic; bound fraction 104–365 μg/g), p-coumaric acid (15–374 μg/g), proanthocyanidins dominated by prodelphinidin B3 (90–197 μg/g), and α-tocotrienol (approximately 47.7% of total tocols at 19.2–54.6 μg/g DW). Measured ABTS radical scavenging capacity ranges from 4.92 to 9 mM Trolox equivalents per gram across cultivars, with Pakistani varieties reaching up to 12.6 mM TE/g, placing two-row barley among moderately potent antioxidant grains in vitro, though human bioavailability data are lacking.
How should I eat two-row barley to get the most health benefits?
Consuming two-row barley as a minimally processed whole grain — pearled or hulled barley cooked in soups, stews, or grain bowls at 50–100 g dry weight per serving — preserves the highest concentration of β-glucans, bound phenolic acids, and tocotrienols compared to refined or flour-based preparations. Consuming barley with meals maximizes β-glucan's glycemic-blunting viscosity effect on co-ingested carbohydrates, and pairing it with vitamin C-rich foods may improve iron bioavailability from the grain; malting and fermentation alter phenolic profiles significantly and should not be assumed nutritionally equivalent to whole grain consumption.
What is the bioavailable form of two-row barley that maximizes β-glucan absorption?
Barley beta-glucan is most bioavailable when consumed as whole grain or soluble fiber extracts rather than whole kernels, as processing increases the accessibility of β-glucan to intestinal absorption. Milling and enzymatic treatment can break down the cell wall structure, enhancing viscosity in the digestive tract where β-glucan exerts its cholesterol-lowering effects. Studies show that consuming barley as a beverage or flour-based product achieves higher plasma glucose responses and greater lipid-lowering effects compared to whole barley consumption.
Is two-row barley safe to consume daily, and are there recommended intake limits?
Two-row barley is safe for daily consumption in typical food amounts (25–50g of soluble fiber content), though excessive intake may cause digestive discomfort such as bloating or gas due to high β-glucan fermentation in the colon. Clinical studies demonstrating cholesterol benefits used doses of 3–10g of barley β-glucan daily without adverse effects, making this a reasonable target for supplementation. Individuals with severe irritable bowel syndrome or digestive sensitivities should introduce barley gradually and monitor tolerance.
How does two-row barley compare to oats and other grains for cardiovascular and antioxidant benefits?
Two-row barley contains comparable or superior β-glucan levels to oats (typically 3–7% in barley vs. 2–6% in oats) and notably higher phenolic acid concentrations (15–374 μg/g) than wheat or rice, making it particularly potent for cardiovascular protection. While oats have stronger brand recognition for heart health, barley's ferulic and p-coumaric acid content provides distinct antioxidant advantages that may synergize with β-glucan for LDL reduction. Both grains are evidence-based choices, though barley may offer superior results for individuals specifically targeting antioxidant defense alongside cholesterol management.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w two-row-barley-hordeum-vulgare-var-distichon curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
